000 01544 a2200385 4500
005 20250517004532.0
264 0 _c20160901
008 201609s 0 0 eng d
022 _a1648-9144
024 7 _a10.1016/j.medici.2014.09.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJuozaitytė, Elona
245 0 0 _aGuidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.
_h[electronic resource]
260 _bMedicina (Kaunas, Lithuania)
_c2014
300 _a197-203 p.
_bdigital
500 _aPublication Type: Consensus Development Conference; Journal Article
650 0 4 _aAromatase Inhibitors
_xadverse effects
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Neoplasms
_xdiagnosis
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLithuania
650 0 4 _aOsteoporosis
_xchemically induced
650 0 4 _aPractice Guidelines as Topic
700 1 _aAleknavičius, Eduardas
700 1 _aJančiauskienė, Rasa
700 1 _aCesas, Alvydas
700 1 _aPipirienė-Želvienė, Teresė
700 1 _aLiutkauskienė, Sigita
700 1 _aKrasauskienė, Aurelija
700 1 _aVencevičienė, Lina
773 0 _tMedicina (Kaunas, Lithuania)
_gvol. 50
_gno. 4
_gp. 197-203
856 4 0 _uhttps://doi.org/10.1016/j.medici.2014.09.004
_zAvailable from publisher's website
999 _c24413043
_d24413043